Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Advances in Experimental Medicine and Biology|November 26, 2008
Compstatin: a complement inhibitor on its way to clinical applicationDaniel Ricklin, John D Lambris
Seminars in Immunopathology|November 25, 2021
Complement & disease: out of the shadow into the spotlightDaniel Ricklin, Richard B Pouw
Advances in Experimental Medicine and Biology|September 26, 2007
Exploring the complement interaction network using surface plasmon resonanceDaniel Ricklin, John D Lambris
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2013
Complement in immune and inflammatory disorders: pathophysiological mechanismsDaniel Ricklin, John D Lambris
Seminars in Immunology|June 21, 2016
New milestones ahead in complement-targeted therapyDaniel Ricklin, John D Lambris
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4HongBin Wang, Daniel Ricklin, John D Lambris
Molecular Immunology|October 6, 2009
Recent developments in low molecular weight complement inhibitorsHongchang Qu, Daniel Ricklin, John D Lambris
Frontiers in Immunology|May 17, 2021
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and PathophysiologyChristina Lamers, Carla Johanna Plüss, Daniel Ricklin
Trends in Pharmacological Sciences|August 15, 2025
Danicopan: complement factor D inhibitor for paroxysmal nocturnal hemoglobinuriaEkaterina Umnyakova, Alexander J Lander, Daniel Ricklin
Immunobiology|September 12, 2012
The XXIV International Complement Workshop (ICW) on October 10-15, 2012. PrefaceJohn D Lambris, George Hajishengallis, Daniel Ricklin
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Advances in Experimental Medicine and Biology|November 26, 2008
Compstatin: a complement inhibitor on its way to clinical applicationDaniel Ricklin, John D Lambris
Seminars in Immunopathology|November 25, 2021
Complement & disease: out of the shadow into the spotlightDaniel Ricklin, Richard B Pouw
Advances in Experimental Medicine and Biology|September 26, 2007
Exploring the complement interaction network using surface plasmon resonanceDaniel Ricklin, John D Lambris
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2013
Complement in immune and inflammatory disorders: pathophysiological mechanismsDaniel Ricklin, John D Lambris
Seminars in Immunology|June 21, 2016
New milestones ahead in complement-targeted therapyDaniel Ricklin, John D Lambris
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4HongBin Wang, Daniel Ricklin, John D Lambris
Molecular Immunology|October 6, 2009
Recent developments in low molecular weight complement inhibitorsHongchang Qu, Daniel Ricklin, John D Lambris
Frontiers in Immunology|May 17, 2021
The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and PathophysiologyChristina Lamers, Carla Johanna Plüss, Daniel Ricklin
Trends in Pharmacological Sciences|August 15, 2025
Danicopan: complement factor D inhibitor for paroxysmal nocturnal hemoglobinuriaEkaterina Umnyakova, Alexander J Lander, Daniel Ricklin
Immunobiology|September 12, 2012
The XXIV International Complement Workshop (ICW) on October 10-15, 2012. PrefaceJohn D Lambris, George Hajishengallis, Daniel Ricklin
Pageof 14